Moreover, there was no significant difference in the percentage of CD3+ T cells and CD19+ B cells in peripheral blood among patients with ulcerative colitis, crohn’s disease, and healthy controls (Figure 2A). This evidence concerns the gene CD19 and ulcerative colitis.